• Motivated and resourceful Commerical leader with significant Market Access, Global Product Strategy, Health Economics Outcomes Research, HTA, Marketing, Medical Affairs, and Pricing Strategy with country, regional and global experience.
• Built and managed Commercial, Value & Access and HTA capabilities, in 3 multinational pharmaceuticals now 4th with oversight on US & Global Market Access, Pricing, Global Product Strategy, Medical Affair’s and HEOR in Oncology, Rare Diseases, CardioVascular and Neuroscience franchises
• Recognized for developing teams and implementing locally tailored patient access and pricing solutions working seamlessly with country operations by appreciating the constraints of their Healthcare Financing, Clinical evidence, and Health Economic /HTA within the framework of their health care delivery system
• 18 year of professional and leadership experience having consistently lead and built high-performance teams who have delivered high double-digit growth in competitive environments
• Recognized for integrating payer insights, scientific, humanistic and real-world evidence with reimbursement strategy in mind
• Known for ability to connect with external stakeholders in academic, policy and Government to build on value proposition and integrate shared value engagements and solutions
• Recipient of 2 Presidents Award for Innovative access & customer solutions and an emerging growth market regional award for customer partnerships
• Contributing member of Novartis Corporate, Pfizer , Shire and Boehringer Ingelheim Global Strategy team, defining new models, to ensure alignment with Governments, NGOs, and Patients to support sustainable access and Accountable member of Leadership Team tasked with reporting to Corporate Enterprise and Board of Directors